BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 29800181)

  • 1. Association Between Intensity of Posttreatment Surveillance Testing and Detection of Recurrence in Patients With Colorectal Cancer.
    Snyder RA; Hu CY; Cuddy A; Francescatti AB; Schumacher JR; Van Loon K; You YN; Kozower BD; Greenberg CC; Schrag D; Venook A; McKellar D; Winchester DP; Chang GJ;
    JAMA; 2018 May; 319(20):2104-2115. PubMed ID: 29800181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of More vs Less Frequent Follow-up Testing on Overall and Colorectal Cancer-Specific Mortality in Patients With Stage II or III Colorectal Cancer: The COLOFOL Randomized Clinical Trial.
    Wille-Jørgensen P; Syk I; Smedh K; Laurberg S; Nielsen DT; Petersen SH; Renehan AG; Horváth-Puhó E; Påhlman L; Sørensen HT;
    JAMA; 2018 May; 319(20):2095-2103. PubMed ID: 29800179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomised controlled trial to assess the cost-effectiveness of intensive versus no scheduled follow-up in patients who have undergone resection for colorectal cancer with curative intent.
    Mant D; Gray A; Pugh S; Campbell H; George S; Fuller A; Shinkins B; Corkhill A; Mellor J; Dixon E; Little L; Perera-Salazar R; Primrose J
    Health Technol Assess; 2017 May; 21(32):1-86. PubMed ID: 28641703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of 3 to 5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer: the FACS randomized clinical trial.
    Primrose JN; Perera R; Gray A; Rose P; Fuller A; Corkhill A; George S; Mant D;
    JAMA; 2014 Jan; 311(3):263-70. PubMed ID: 24430319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No benefit of more intense follow-up after surgery for colorectal cancer in the risk group with elevated CEA levels - An analysis within the COLOFOL randomized clinical trial.
    Egenvall M; Martling A; Veres K; Horváth-Puhó E; Wille-Jørgensen P; Høirup Petersen S; Laurberg S; Sørensen HT; Syk I;
    Eur J Surg Oncol; 2021 Aug; 47(8):2053-2059. PubMed ID: 33846037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical follow-up does not improve survival after resection of stage I-III colorectal cancer: A cohort study.
    Jones RP; McWhirter D; Fretwell VL; McAvoy A; Hardman JG
    Int J Surg; 2015 May; 17():67-71. PubMed ID: 25827817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Predictive value of combination detection of tissue Pgp1 expression and preoperative serum CEA level for colorectal cancer].
    Wu F; Chen L; Wu W; Jiang B; Su X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Apr; 20(4):443-449. PubMed ID: 28440527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival Outcomes in Asymptomatic Patients With Normal Conventional Imaging but Raised Carcinoembryonic Antigen Levels in Colorectal Cancer Following Positron Emission Tomography-Computed Tomography Imaging.
    Khan K; Athauda A; Aitken K; Cunningham D; Watkins D; Starling N; Cook GJ; Kalaitzaki E; Chau I; Rao S
    Oncologist; 2016 Dec; 21(12):1502-1508. PubMed ID: 27742904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of serum carcinoembryonic antigen in the detection of colorectal cancer before and after surgical resection.
    Su BB; Shi H; Wan J
    World J Gastroenterol; 2012 May; 18(17):2121-6. PubMed ID: 22563201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Comparative Surveillance Strategies of Circulating Tumor DNA, Imaging, and Carcinoembryonic Antigen Levels in Patients With Resected Colorectal Cancer.
    Fakih M; Sandhu J; Wang C; Kim J; Chen YJ; Lai L; Melstrom K; Kaiser A
    JAMA Netw Open; 2022 Mar; 5(3):e221093. PubMed ID: 35258578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of a dedicated cancer center surveillance program on guideline adherence for patients with stage II and III colorectal cancer.
    Standeven L; Price Hiller J; Mulder K; Zhu G; Ghosh S; Spratlin JL
    Clin Colorectal Cancer; 2013 Jun; 12(2):103-12. PubMed ID: 23153862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated serum carcinoembryonic antigen level after curative surgery is a prognostic biomarker of stage II-III colorectal cancer.
    Sonoda H; Yamada T; Matsuda A; Ohta R; Shinji S; Yokoyama Y; Takahashi G; Iwai T; Takeda K; Ueda K; Kuriyama S; Miyasaka T; Yoshida H
    Eur J Surg Oncol; 2021 Nov; 47(11):2880-2887. PubMed ID: 34103245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Community compliance with carcinoembryonic antigen: follow-up of patients with colorectal cancer.
    Spratlin JL; Hui D; Hanson J; Butts C; Au HJ
    Clin Colorectal Cancer; 2008 Mar; 7(2):118-25. PubMed ID: 18501071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic role of carcinoembryonic antigen is influenced by microsatellite instability genotype and stage in locally advanced colorectal cancers.
    Søreide K; Søreide JA; Kørner H
    World J Surg; 2011 Apr; 35(4):888-94. PubMed ID: 21301835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic impact of carcinoembryonic antigen and carbohydrate antigen 19-9 in stage IV colorectal cancer patients after R0 resection.
    Abe S; Kawai K; Ishihara S; Nozawa H; Hata K; Kiyomatsu T; Tanaka T; Watanabe T
    J Surg Res; 2016 Oct; 205(2):384-392. PubMed ID: 27664887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postoperative surveillance in patients with colorectal cancer who have undergone curative resection: a prospective, multicenter, randomized, controlled trial.
    Rodríguez-Moranta F; Saló J; Arcusa A; Boadas J; Piñol V; Bessa X; Batiste-Alentorn E; Lacy AM; Delgado S; Maurel J; Piqué JM; Castells A
    J Clin Oncol; 2006 Jan; 24(3):386-93. PubMed ID: 16365182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tumor surveillance after resection of colorectal cancer].
    Vorburger SA; Gloor B; Candinas D
    Ther Umsch; 2008 Jun; 65(6):329-34. PubMed ID: 18622956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of carcinoembryonic antigen for the detection of recurrent disease following curative resection of large-bowel cancer.
    Wichmann MW; Müller C; Lau-Werner U; Strauss T; Lang RA; Hornung HM; Stieber P; Schildberg FW
    Langenbecks Arch Surg; 2000 Jul; 385(4):271-5. PubMed ID: 10958511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative serum carcinoembryonic antigen, albumin and age are supplementary to UICC staging systems in predicting survival for colorectal cancer patients undergoing surgical treatment.
    Sun LC; Chu KS; Cheng SC; Lu CY; Kuo CH; Hsieh JS; Shih YL; Chang SJ; Wang JY
    BMC Cancer; 2009 Aug; 9():288. PubMed ID: 19691850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of patients with high-risk for pulmonary metastases after curative resection of colorectal cancer.
    Anannamcharoen S; Boonya-Ussadol C
    J Med Assoc Thai; 2012 May; 95 Suppl 5():S86-91. PubMed ID: 22934451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.